ICAM1 and neoplasm: Blockade of CD11b, the ligand for ICAM-1, in a transplantable murine squamous carcinoma model significantly reduced tumor-infiltration by CD11b+ myeloid cells following RT resulting in diminished tumor growth (Ahn et al., 2010).